Page last updated: 2024-08-26

uftoral and Anemia

uftoral has been researched along with Anemia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byun, JH; Choi, MG; Chung, IS; Hong, YS; Kang, JH; Kim, KW; Lee, KS; Lee, MA; Moon, DH; Park, SY; Shim, BY; Woo, IS1
Maeda, Y; Makuuchi, H; Murayama, C; Sadahiro, S; Suzuki, T1
Ayala, F; Casado, A; Diaz-Rubio, E; López-Martin, JA; Martin, M; Nieto, Y; Rodriguez-Lescure, A1
Diaz-Rubio, E; Garcia Carbonero, I; González-Larriba, JL; Perez Segura, P; Sastre Valera, J1
Ichinose, Y; Kuba, M; Kudoh, S; Morikawa, T; Niitani, H; Yano, T; Yoshimori, K1
Belón, J; de Castro, J; Espinosa, E; Feliu, J; García Alfonso, P; García Girón, C; Garrido, P; González Barón, M; Lomas, M; Ordóñez, A; Zamora, P1

Trials

5 trial(s) available for uftoral and Anemia

ArticleYear
A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
    Japanese journal of clinical oncology, 2005, Volume: 35, Issue:1

    Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Combinations; Epirubicin; Female; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Uracil

2005
[Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Tegafur; Uracil

2006
Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.
    Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:9 Suppl 10

    Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Drug Combinations; Female; Fluorouracil; Forecasting; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil

1997
UFT plus cisplatin in advanced non-small-cell lung cancer: interim analysis of 67 patients.
    Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:9 Suppl 10

    Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Combinations; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Tegafur; Thrombocytopenia; Uracil; Vomiting

1997
The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group.
    Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:9 Suppl 10

    Topics: Anemia; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Combinations; Etoposide; Female; Forecasting; Humans; Leucovorin; Male; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Uracil

1997

Other Studies

1 other study(ies) available for uftoral and Anemia

ArticleYear
Preliminary results. UFT/methotrexate/leucovorin for breast Ca patients in progression after HDCT/PBPC support.
    Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:9 Suppl 10

    Topics: Adult; Anemia; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diarrhea; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Neutropenia; Survival Rate; Tegafur; Uracil

1997